Recurrent Atypical Chronic Myeloid Leukemia
1 clinical trials · Condition
◉ Watch Recurrent Atypical Chronic Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms (NCT05549661) | Mayo Clinic | 2023-04-04 |
Track Recurrent Atypical Chronic Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.